Practolol in Treatment of Supraventricular Cardiac Dysrhythmias
- 28 February 1970
- Vol. 1 (5695), 533-535
- https://doi.org/10.1136/bmj.1.5695.533
Abstract
Practolol (I.C.I. 50172) was used to treat supraventricular dysrhythmias in 32 patients with a rapid ventricular rate and with heart disease of varied aetiology. In 26 patients the average reduction in ventricular rate was 75 per minute, while immediate reversion to sinus rhythm occurred in three patients. The slowing effect was mainly due to a direct action on the atrioventricular node. The effectiveness of practolol was unrelated to the type of dysrhythmia or its aetiology. No serious adverse clinical effects were noted.Keywords
This publication has 7 references indexed in Scilit:
- PRACTOLOL IN THE TREATMENT OF CARDIAC DYSRHYTHMIAS DUE TO ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1969
- Haemodynamic Responses to Exercise in Hypertension: Place of the Sympathetic Nervous System Evaluated by a New Selective Cardiac Beta-adrenergic Blocking Agent ICI 50,172Cardiovascular Research, 1968
- Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exerciseBritish Journal of Pharmacology, 1968
- Clinical Use of I.C.I. 50172 as an Antidysrhythmic Agent in Heart FailureBMJ, 1968
- Cardiac failure in patients with valvar heart disease after use of propranolol to control atrial fibrillation.BMJ, 1968
- Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease.BMJ, 1968
- Beta-adrenergic Receptor Blockade in Cardiac ArrhythmiasBMJ, 1963